Evaluation of Efficacy and Safety of the triLift™ System (LUM-triLift)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Fiona Kerr
- Phone Number: 212-249-9440
- Email: nurses@nylaserskincare.com
Study Locations
-
-
New York
-
New York, New York, United States, 10028
- Recruiting
- NY Laser Skin Care
-
Contact:
- Arielle Kauvar, MD
- Phone Number: 212-249-9440
- Email: info@nyskincare.com
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Subject is willing and able to read, understand, and sign the informed consent.
- Healthy male or female aged 35 - 55 years.
- Fitzpatrick skin type 1-6.
- Subject is capable of reading, understanding, and following instructions of the procedure to be applied.
- Subject is able and willing to comply with the treatment. Women in childbearing age who is willing to conduct a pregnancy test prior to each treatment.
Exclusion Criteria:
- Pregnant, lactating, or plans to become pregnant during the study period or had given birth less than 6 months ago.
- Concurrent participation in any other study.
- Subject has a pacemaker or internal defibrillator, implanted neurostimulators or any other internal electric device or patient who had an implant in the past.
- Subject has metal or other implants in the treatment area (Not including dental fillings, implants and crowns).
- Subject has significant concurrent skin conditions affecting areas to be treated such as sores, bleeding, skin fragility, eczema or psoriasis.
- Subject has burned, blistered, irritated, or sensitive skin due to excessive fresh tanning in areas to be treated or is unlikely to refrain from excessive tanning during the study.
- Subject has used oral isotretinoin (Accutane® or Roaccutan®) within 6 months prior to study.
- Subject has used topical retinoids in the past 1 month.
- History of systemic cancer; premalignant skin lesion or skin concern treatment area.
- Concurrent conditions such as epilepsy, autoimmune, pulmonary or cardiac disorders.
- Poorly controlled endocrine disorders such as diabetes.
- Impaired immune system due to immunosuppressive diseases such as HIV or AIDS, or use of immunosuppressive medications.
- History of collagen disorders, keloid formation or abnormal wound healing.
- Takes or has taken medications, herbal preparations, food supplements or vitamins that might cause fragile skin or impaired skin healing.
- Subject has used oral steroids in the past 6 months.
- Subject has used topical steroids in the past 3 months.
- History of bleeding coagulopathies or use of anticoagulants.
- Use of non-steroidal anti-inflammatory drugs (NSAIDS, e.g. ibuprofen containing agents) one week before and after each treatment session prior to treatment.
- Subjects who cannot feel heat to give proper treatment feedback. (nerve damage, etc.)
- Mental disorders that in the opinion of the Investigator would interfere with the ability to comply with the study requirements.
- Subject has any other medical condition that in the opinion of the Investigator warrants exclusion from this study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Other: Trilift system treatment arm
Single arm with Before & After photos, triLift treatment protocol study design.
|
To evaluate the efficacy of the triLift™ treatment
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Global Aesthetic Improvement scale (GAI)
Time Frame: 4 months
|
The Global Aesthetic Improvement scale (GAI) - Success is defined as an improvement of at least 1 point on the GAI scale assessed by the investigator, at the end of the treatment protocol as compared to baseline.
|
4 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
3D images
Time Frame: 4 months
|
Measuring facial lifting using 3D imaging and analysis algorithm from Quantificare before and after the treatment protocol
|
4 months
|
|
Comfort assessment
Time Frame: 3 months
|
Subject assessment of pain and discomfort associated with treatments using a Pain Visual Analogue Scale (VAS), where 0 is "no pain" and 10 is "worst pain possible
|
3 months
|
|
Subject level of Satisfaction
Time Frame: 4 months
|
Subject satisfaction will be assessed using a 5 level satisfaction questionnaire.
|
4 months
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Arielle Kauvar, MD, New York Laser & Skin Care
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- LUM-ABU-triLift-22-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.